This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Osoegawa, A. Articles by Maehara, Y. Search for Related Content PubMed PubMed Citation Articles by Osoegawa, A. Articles by Maehara, Y.

Regulation of p27 by S-Phase Kinase-Associated Protein 2 Is Associated With Aggressiveness in Non–Small-Cell Lung Cancer

From the Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka; and Department of Surgery II, Graduate School of Medical Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan

Address reprint requests to Ichiro Yoshino, MD, PhD, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan; e-mail: iyoshino{at}surg2.med.kyushu-u.ac.jp

PURPOSE: The F-box protein S-phase kinase-associated protein 2 (Skp2) is one of the positive regulators of the cell cycle that promote ubiquitin-mediated proteolysis of the cyclin-dependent kinase inhibitor p27. In this study, we investigated the significance of Skp2 expression in human non–small-cell lung cancer (NSCLC).

PATIENTS AND METHODS: Clinicopathologic features and immunohistochemical expression of Skp2 and p27 proteins were studied in 138 patients with NSCLC. Survival analyses were performed using the Kaplan-Meier method and the Cox regression model. To analyze the role of Skp2 in vitro, NSCLC cells were transfected with an Skp2-expressing vector or small interfering RNA.

RESULTS: Skp2 was overexpressed in males, smokers, patients with squamous cell carcinomas, and patients with poorly differentiated cancers (P = .034, < .0001, < .0001, and .002, respectively). The multivariant analysis revealed that Skp2 expression is an independent prognostic factor for survival in NSCLC. An inverse relationship of Skp2 with p27 expression was observed (P = .012), and patients with both a higher expression of Skp2 and a lower expression of p27 showed a significantly unfavorable prognosis (P = .0002). In vitro ectopic expression of Skp2 in NSCLC cells reduced the protein level of p27. Conversely, induction of Skp2 siRNA increased the protein level of p27, leading to growth inhibition in NSCLC cells.

CONCLUSION: Skp2 overexpression is closely associated with the suppression of p27 and the aggressiveness in NSCLC. It also could be a therapeutic target in NSCLC.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				T. Fujita, W. Liu, H. Doihara, and Y. Wan Regulation of Skp2-p27 Axis by the Cdh1/Anaphase-Promoting Complex Pathway in Colorectal Tumorigenesis Am. J. Pathol., July 1, 2008; 173(1): 217 - 228. [Abstract] [Full Text] [PDF]

				H.-C. Chang, F.-R. Chang, Y.-C. Wang, M.-R. Pan, W.-C. Hung, and Y.-C. Wu A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression Mol. Cancer Ther., May 1, 2007; 6(5): 1572 - 1578. [Abstract] [Full Text] [PDF]

				I. Yoshino, D. Kawano, T. Oba, K. Yamazaki, T. Kometani, and Y. Maehara Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ann. Thorac. Surg., April 1, 2006; 81(4): 1189 - 1193. [Abstract] [Full Text] [PDF]

				T. Matsunobu, K. Tanaka, T. Nakamura, F. Nakatani, R. Sakimura, M. Hanada, X. Li, T. Okada, Y. Oda, M. Tsuneyoshi, et al. The Possible Role of EWS-Fli1 in Evasion of Senescence in Ewing Family Tumors Cancer Res., January 15, 2006; 66(2): 803 - 811. [Abstract] [Full Text] [PDF]